Tech-Based Caregiver Support for Alzheimer's Disease

(TACAD Trial)

No longer recruiting at 2 trial locations
EI
WC
WC
Overseen ByWonshik Chee, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Texas at Austin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial evaluates a tech-based support program designed to assist Asian American midlife women caring for family members with Alzheimer's disease. Researchers aim to determine if this program, called TACAD (Technology-based information and coaching/support program tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease), can improve health outcomes for both caregivers and their loved ones. Participants will either use the TACAD program along with the Alzheimer's Association Website or just the website alone. Ideal candidates are Asian American women, aged 40 to 65, who provide at least four hours of daily care to a family member with early to middle-stage Alzheimer's, live in the U.S., and have internet access. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance caregiver support and improve quality of life.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the TACAD program is safe for caregivers?

Research has shown that the TACAD program is a tech-based support system designed to assist Asian American women caring for family members with Alzheimer's. Although specific data on TACAD's safety is not available, it is likely safe as it is a technology program, not a medication. Tech-based programs typically offer information and support without the side effects associated with medications. The program uses online resources, which generally do not pose safety risks.12345

Why are researchers excited about this trial?

Researchers are excited about TACAD for Alzheimer's disease because it offers tech-based support specifically for caregivers, which is not a focus of existing treatments. Unlike the standard of care that primarily involves medications like donepezil or rivastigmine aimed at slowing cognitive decline in patients, TACAD leverages technology to enhance caregiver support. By integrating the use of the Alzheimer's Association Website with TACAD, this approach could improve caregiver well-being and, in turn, positively impact patient care. This innovation could lead to a more holistic management of Alzheimer's by addressing the needs of both patients and their caregivers.

What evidence suggests that the TACAD program is effective for supporting caregivers of Alzheimer's patients?

Research shows that technology-based support programs like TACAD, available to participants in this trial, can help caregivers improve their health. These programs offer information and guidance specifically for Asian American women in midlife caring for loved ones with Alzheimer's disease. Early results suggest that personalized support can lower stress and enhance caregivers' well-being. Although specific data on TACAD is still being gathered, similar programs have demonstrated positive effects on mental health and have alleviated challenges faced by caregivers. This suggests that TACAD might effectively provide essential support and relief for these caregivers.12467

Who Is on the Research Team?

EI

Eun-Ok Im, PhD, MPH

Principal Investigator

University of Texas at Austin

Are You a Good Fit for This Trial?

This trial is for Asian American women, aged 40-65, who are Chinese or Korean and care for family members with early to middle-stage Alzheimer's. They must read/write English, Mandarin, or Korean, live in the U.S., have internet access, and provide at least 4 hours of daily unpaid care without plans for institutionalizing the patient within six months.

Inclusion Criteria

Reside in the U.S.
Family caregivers of PLAD
Caregivers may or may not reside with their care recipient
See 4 more

Exclusion Criteria

Those who used the AA website previously and/or participated in other studies related to AD

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a technology-based program for 3 months, with weekly group and individual coaching/support for the intervention group.

12 weeks
Weekly virtual interactions

Follow-up

Participants are monitored for changes in caregiver and care recipient outcomes through Internet surveys.

4 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Alzheimer's Association website
  • TACAD
Trial Overview The study tests a program called TACAD against using the Alzheimer's Association website. It aims to see if TACAD can better improve health outcomes for these caregivers and their patients living with Alzheimer's disease by providing tailored information and coaching/support.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
Group II: Active Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas at Austin

Lead Sponsor

Trials
387
Recruited
86,100+

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

Published Research Related to This Trial

A study involving 16 Latino caregivers aged 50 to 75 revealed that caregiver responsibilities and health decline were significant sources of burden for those caring for family members with Alzheimer's disease and related dementia.
Cultural values, particularly gender roles, influenced caregivers' experiences, highlighting disparities in support and responsibilities, with women feeling a greater burden due to traditional expectations.
Sources of Caregiving Burden in Middle-Aged and Older Latino Caregivers.Balbim, GM., Magallanes, M., Marques, IG., et al.[2021]
The REACH VN intervention, designed for family caregivers of individuals with dementia, will be tested in a large-scale cluster randomized controlled trial involving approximately 350 caregivers in Vietnam, aiming to assess its efficacy in reducing caregiver burden and psychological distress over 2 to 3 months.
This study is significant as it is the first of its kind in Vietnam to evaluate a community-based support program for dementia caregivers, potentially influencing future caregiver support initiatives in low- and middle-income countries.
Resources for Enhancing Alzheimer's Caregiver Health in Vietnam (REACH VN): study protocol for a cluster randomized controlled trial to test the efficacy of a family dementia caregiver intervention in Vietnam.Tran, D., Nguyen, H., Pham, T., et al.[2023]
Many Latino individuals interested in participating in Alzheimer's disease research face significant barriers, including a lack of knowledge about the disease and misconceptions about memory loss being a normal part of aging.
Structural challenges in accessing care and feelings of being overwhelmed among caregivers contribute to low participation rates in Alzheimer's studies, highlighting the need for improved outreach and education within Latino communities.
Learning from recruitment challenges: barriers to diagnosis, treatment, and research participation for Latinos with symptoms of Alzheimer's disease.Gelman, CR.[2022]

Citations

TACAD Program for Asian American Family Caregivers of ...The purpose of the proposed study is to preliminarily evaluate a technology-based program in improving health outcomes of Asian American midlife women who are ...
Project Details - NIH RePORTERThe purpose of this 2-phase, mixed- methods, exploratory study is to preliminarily evaluate TACAD in improving health outcomes of Asian American midlife women ...
TACAD Program for Asian American Family Caregivers of ...The purpose of the proposed study is to preliminarily evaluate a technology-based program in improving health outcomes of Asian American midlife women who are ...
TACAD Program for Asian American Family Caregivers of ...The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored ...
Project Details - NIH RePORTERThe purpose of this 2-phase, mixed- methods, exploratory study is to preliminarily evaluate TACAD in improving health outcomes of Asian American midlife women.
Tech-Based Caregiver Support for Alzheimer's Disease ...TACAD is unique because it is a technology-based program specifically designed to support Asian American midlife women who are family caregivers of Alzheimer's ...
GENERAL STUDY INFORMATIONcoaching/support program, TACAD (Technology-based Information and Coaching/Support Program for Asian ... information below regarding confidentiality and data ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security